| 前收市價 | 28.07 |
| 開市 | 28.05 |
| 買盤 | 28.08 x 30000 |
| 賣出價 | 28.30 x 30000 |
| 今日波幅 | 28.05 - 28.05 |
| 52 週波幅 | 24.08 - 36.25 |
| 成交量 | |
| 平均成交量 | 5 |
| 市值 | 3.83B |
| Beta 值 (5 年，每月) | 0.65 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.03 |
| 業績公佈日 | 無 |
| 遠期股息及收益率 | 1.01 (3.60%) |
| 除息日 | 2024年3月07日 |
| 1 年預測目標價 | 51.00 |
Insider MonkeyHere’s Why Perrigo Company PLC (PRGO) Stock Slumped in Q1
Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The portfolio had a 5.7% gain in the first quarter compared to an 8.2% return in the Russell Midcap Value Index. The Strategy underperformed in Financials and Industrials due […]
FortuneThe WNBA has partnered with Glossier and Skims—now it’s added Opill, the new over-the-counter birth control
Pharma company Perrigo plans to spread the word about Opill at the WNBA draft.
- Reuters
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors
CVS Caremark, the pharmacy benefit management subsidiary of CVS Health Corp, will add Perrigo's birth control pill to its preventive services oral contraceptives list and make it available at no cost for many plan sponsors, according to a pharmacy update on March 28. The U.S. FDA in July approved over-the-counter use of Perrigo's drug Opill, making it the first oral contraceptive in the country which can be purchased without prescription.
